Vedolizumab vs placebo
Failure to induce endoscopic remission · Patients with moderately to severely active ulcerative colitis
Vedolizumab leads to lower failure to induce endoscopic remission compared with placebo (high certainty).
1 finding from 1 review
- Vedolizumab for induction and maintenance of remission in ulcerative colitis 2014 · Cochrane Headline outcomes onlyRR 0.82 [0.75, 0.91]3 studies · 583 participantsHigh